openPR Logo
Press release

Biosimilars Market to Witness a Pronounce Growth by Key Players: 3SBIO, Qilu Pharmaceutical, Novartis International AG, Pfizer, STADA Arzneimittel, Beijing SL Pharmaceutical Co and More

02-07-2019 06:11 AM CET | Industry, Real Estate & Construction

Press release from: Allied Market Research

ASEAN and China Biosimilars Market

ASEAN and China Biosimilars Market

The ASEAN and China biosimilars market was valued at $687.6 million in 2017 and is expected to reach $5,506.2 million by 2025 with a CAGR of 29.7% during the forecast period.

The major companies profiled in the report include 3SBIO Inc., Qilu Pharmaceutical, Novartis International AG (Sandoz International GmBH), Pfizer Inc. (Hospira), STADA Arzneimittel, Beijing SL Pharmaceutical Co., Ltd., Fosun Pharmaceutical (Shanghai Fosun Pharmaceutical Co., Ltd.), Amgen Inc., AstraZeneca Plc, and Teva Pharmaceutical Industries Ltd.

Get Sample PDF Brochure of ASEAN and China Biosimilars Market Study at : https://www.alliedmarketresearch.com/request-sample/5080

Biologics experiences rapid growth in the pharmaceutical industry that fuels the development of new treatments for life-threatening and rare illnesses. However, expiry of patents of the biologics that incorporate recombinant technology has been on the rise in recent years. Thus, research-based and generic pharmaceutical companies are pursuing the opportunity to develop "generic" substitutes for original biologics that are known as biosimilars.

The ASEAN and China biosimilars market is segmented into molecule type, application, and region. Based on molecule type, the market is divided into human growth hormone, erythropoietin, monoclonal antibodies, insulin, interferon, granulocyte-colony stimulating factor, and peptide. Based on application, the market is classified into blood disorders, oncology diseases, chronic and autoimmune diseases, growth hormone deficiency, and others. Further, the chronic and autoimmune diseases segment is sub-categorized into diabetes, rheumatoid arthritis (RA), glaucoma, and others. Based on region, the market is analyzed across China and ASEAN region.

Molecule Type segment review

ASEAN and China biosimilars market comprises seven molecule types, namely, human growth hormone, erythropoietin, monoclonal antibody, insulin, interferon, granulocyte-colony stimulating factor, and peptide. The monoclonal antibody segment generated the highest revenue in 2017 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the diverse diagnostic applications of the monoclonal antibodies (mAbs) technology in the healthcare industry.

In addition, mAbs are increasingly applied in the development of novel treatment options for cancer, infectious, cardiovascular, and inflammatory diseases. The human growth hormone segment is anticipated to grow at a rapid pace from 2018 to 2025 in the ASEAN and China biosimilars market. Increase in the development of new treatment plans that involve shift from originator to biosimilar human growth hormone across the ASEAN countries and China has contributed to the robust growth of the segment.

The key driving factors of the ASEAN and China biosimilars market include rise in the number of blockbuster drugs whose patents would be expiring along with high prevalence of chronic diseases among the ageing population across the ASEAN countries and China. In addition, lower cost of biosimilars drugs than original biologics has fueled the market growth. However, high initial investment in R&D is anticipated to hamper the growth of the market. Moreover, increased focus of the international key players to invest in untapped economies of the ASEAN region and China offers lucrative opportunities for expansion of the biosimilars market.

Do Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/5080

Key Benefits ASEAN and China Biosimilars Market:

• The study provides an in-depth analysis along with the current trends and future estimations of the ASEAN and China biosimilars market to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided.
• The quantitative analysis of the industry from 2017 to 2025 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• An extensive analysis of the key segments of the industry is provided to understand the molecule type and applications of biosimilars across ASEAN countries and China.
• The key players and their strategies are analyzed to understand the competitive outlook of the market.

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market to Witness a Pronounce Growth by Key Players: 3SBIO, Qilu Pharmaceutical, Novartis International AG, Pfizer, STADA Arzneimittel, Beijing SL Pharmaceutical Co and More here

News-ID: 1567092 • Views: 536

More Releases from Allied Market Research

Electric Passenger Car Traction Motor Market Growth 2027 – Key drivers, Busine …
Traction motor produces resistance between two surfaces with or without using electricity. An electric passenger car traction motor is a vital component which is used for extracting electricity from the battery pack. Traction motor is installed in electric passenger vehicles to provide rotation torque for the movement of the car. Furthermore, stringent emission discharge norms and regulations drives the demand for electric passenger car. Moreover, quick expansion of EV charging
Electric Passenger Car Lithium-Ion Battery Management System Market Analysis of …
Electric passenger car has gained a considerable consumer popularity & acceptance in the past few years. Major improvements in the performance of an electric passenger car such as high acceleration rate and long driving range after a single charge have been boosting the demand for electric passenger vehicle. Further, a lithium-ion battery (LIB) is a type of rechargeable battery, which is popularly used in the field of electric passenger vehicles
Electric Bus Door System Market Trending Technologies, Developments, Key Players …
Buses have had a strong place in the transportation industry since the 1830s when the first steam bus was introduced in London. Since the year 1830, buses are considered as the most common mode of public transportation in almost every country across the world. Electric bus door system is an assembly of interconnected mechanisms which utilizes the power of electricity to automatically open the door. Furthermore, the electric bus
Commercial Vehicle & Off-Highway RADAR Market Trends, Segments, Emerging Technol …
Commercial & off-highway vehicles are large and utilized for multiple tasks such as transport of goods, mining, excavation, and others. Due to their large sizes and complicated applications, these vehicles are prone to accidents. Safety concerns increase with a high number of blind spots, thereby propelling the use of RADARs in these vehicles to alert the driver of various threats. In addition, safety & security has become a topmost priority

All 5 Releases


More Releases for ASEAN

The 5th ASEAN Energy Outlook: ASEAN is on Track to Reach Their Energy Intensity …
Manila, 28 September 2017 – During the press conference for the 35th ASEAN Ministers on Energy Meeting (AMEM) and Associated Meetings today, ASEAN Centre for Energy (ACE) announced the launch of the 5th ASEAN Energy Outlook (AEO5). The Philippine Secretary of Energy, Alfonso G. Cusi, stated, “The Outlook provides us with pathway to address our long-term goals of achieving energy security, accessibility and affordability within the framework of sustainable development,
ASEAN Confectionery Market to Witness Steady Growth through 2025
ASEAN Confectionery Market Overview Items in confectionery market consists of candies, chocolates, toffees, lollies, bakery items;basically food items that are rich in sugar and sweet content. Mostly confectionery market items consists of food products like butter, cocoa, honey, milk, flour, fruits, honey, nuts, sugar syrup and more. They are consumed globally, mostly by all regions and countries and are expected to grow in developing countries. Confectionery market is growing in mostly
ASEAN Protein Expression Market Analysis, Forecast, and Assessment 2015 - 2025
ASEAN Confectionery Market Overview Items in confectionery market consists of candies, chocolates, toffees, lollies, bakery items;basically food items that are rich in sugar and sweet content. Mostly confectionery market items consists of food products like butter, cocoa, honey, milk, flour, fruits, honey, nuts, sugar syrup and more. They are consumed globally, mostly by all regions and countries and are expected to grow in developing countries. Confectionery market is growing in mostly
ASEAN Automotive Aftermarket to Grow at 9.6% CAGR through 2026
In Future Market Insights’ market report titled, “Automotive Aftermarket: ASEAN Industry Analysis and Opportunity Assessment, 2016-2026”, poor road infrastructure and extended vehicle life have been identified as profitable factors for the growth of the automotive aftermarket in ASEAN. On account of growing out-of-warranty car parc, the US$ 19.3 Bn ASEAN automotive aftermarket is predicted to surpass US$ 48 Bn in revenues by 2026 end, increasing at a healthy CAGR of
Research Offers 10-Year Forecast on ASEAN Cosmetic Chemicals Market
The growing beauty products market has been increasing the demand for value-enriched cosmetics. The market is flooded with various cosmetic chemicals. Cosmetic chemicals are the basic ingredients found in cosmetic products including soap, shampoo, lipstick, mascara, deodorants and other beauty products (excluding the products listed under therapeutic goods). At present, various cosmetic business enterprises use more than 5000 different chemical compositions to offer selected cosmetic products. Based on its end
Lanka IOC retains MTI for second phase of ASEAN entry
Lanka IOC, having successfully completed the market mapping of Indonesia and Myanmar for lubricants with MTI Consulting, has now re-appointed MTI to execute the second phase of in-country distribution operations Speaking to media, the Managing Director of Lanka IOC Mr. Subodh Dakwale said "The MTI study has given us the market map and pulse of the lubricant market in these two key emerging markets of Indonesia and Myanmar. We are